RBD-S SARS-CoV-2 vaccine (United Immunity/BNC Korea)

N/A

Report date: 2025/03/20 09:33:16

Base Information

Drug NameRBD-S SARS-CoV-2 vaccine (United Immunity/BNC Korea)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUnited Immunity Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUnited Immunity Co LtdBNC Korea Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A